Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
2-2
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.3.4
advertisement
11.3.4 Betablocker
(9)
Showing records 1 to 9
Display all abstracts in classification
11.3.4 Betablocker
Search within classification 11.3.4 Betablocker
6093
Timolol lowers intraocular pressure but does not inhibit the development of experimental myopia in chick
Schmid KL; Abbott M; Humphries M; Pyne K; Wildsoet CF
Experimental Eye Research
2000; 70: 659-666
6165
The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension: a six-month, randomized, multicenter study
Diestelhorst M; Hutz; Schmickler; Diestelhorst; Wiedemann; Henjes; Borchart; Lang; Schmitz-Valckenberg P; Mester
Graefe's Archive for Clinical and Experimental Ophthalmology
2000; 238: 433-439
6170
Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular hypertension: a randomized clinical trial
Javitt JC; Schiffman RH
Journal of Glaucoma
2000; 9: 224-234
6173
Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol: Brimonidine Study Groups 1 and 2.
Schuman JS
Ophthalmology
2000; 107: 1171-1177
6178
A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol
Hedman K; Alm A
European Journal of Ophthalmology
2000; 10: 95-104
6179
Vasorelaxing properties of carteolol in isolated porcine ciliary arteries
Kasper J; Champion C; Flammer J; Haefliger IO
Klinische Monatsblätter für Augenheilkunde
2000; 216: 318-320
6180
Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension
Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
Investigative Ophthalmology and Visual Science
2000; 41: 2566-2573
6181
Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with timoptic XE 0.5% in a 12-month study
Schenker HI; Silver LH
American Journal of Ophthalmology
2000; 130: 145-150
6182
Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye
Sponsel WE; Mensah J; Kiel JW; Trigo Y; Baca W; Friberg T
American Journal of Ophthalmology
2000; 130: 151-159
Issue
2-2
Table of Contents
Editor's Selection
Change Issue
24-2 (2024)
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement